{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:43:59Z","timestamp":1790703839183,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.det.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T18:36:39Z","timestamp":1565116599000},"page":"471-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lymphomatoid Papulosis and Other Lymphoma-Like Diseases"],"prefix":"10.1016","volume":"37","author":[{"given":"Adrian","family":"Moy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Seminario-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13671-013-0054-x","article-title":"Pityriasis lichenoides and cutaneous T cell lymphoma: an update on the diagnosis and management of the most common benign and malignant cutaneous lymphoproliferative diseases in children","volume":"2","author":"Boos","year":"2013","journal-title":"Curr Dermatol Rep"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00128071-200708010-00004","article-title":"Pityriasis lichenoides: pathophysiology, classification, and treatment","volume":"8","author":"Khachemoune","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2005.07.058","article-title":"Pityriasis lichenoides and its subtypes","volume":"55","author":"Bowers","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2019.05.005_bib4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1365-4632.2012.05608.x","article-title":"Pityriasis lichenoides in an Asian population","volume":"52","author":"Koh","year":"2013","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib5","first-page":"125","article-title":"Pityriasis lichenoides chronica in black patients","volume":"85","author":"Lane","year":"2010","journal-title":"Cutis"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0378-6323.31894","article-title":"A\u00a0clinical and histopathological study of pityriasis lichenoides","volume":"73","author":"Nair","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"10.1016\/j.det.2019.05.005_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40257-016-0216-2","article-title":"Phototherapy for pityriasis lichenoides in the pediatric population: a review of the published literature","volume":"17","author":"Maranda","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/pde.13396","article-title":"Pityriasis lichenoides: long-term follow-up study","volume":"35","author":"Zang","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/pde.12581","article-title":"Pityriasis lichenoides in childhood: review of clinical presentation and treatment options","volume":"32","author":"Geller","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.det.2019.05.005_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archderm.1987.01660340097028","article-title":"Clinical and histologic features of pityriasis lichenoides et varioliformis acuta in children","volume":"123","author":"Longley","year":"1987","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jdcr.2016.03.002","article-title":"A\u00a0fatal case of febrile ulceronecrotic Mucha-Habermann disease in a child","volume":"2","author":"Nofal","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.det.2019.05.005_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4103\/ijd.IJD_631_16","article-title":"A\u00a0fatal case of febrile ulceronecrotic mucha-habermann disease which presenting as toxic epidermal necrolysis","volume":"62","author":"Xing","year":"2017","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2019.05.005_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ced.13549","article-title":"Varicella zoster virus as a possible trigger for the development of pityriasis lichenoides et varioliformis acuta: retrospective analysis of our institutional cases","volume":"43","author":"Horie","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1525-1470.2012.01821.x","article-title":"Varicella-zoster virus as a possible cause of pityriasis lichenoides et varioliformis acuta","volume":"31","author":"Cho","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib15","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1111\/j.1440-0960.2011.00781.x","article-title":"Pityriasis lichenoides et varioliformis acuta: a rare association with the measles, mumps and rubella vaccine","volume":"53","author":"Gunatheesan","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"3 Suppl 1","key":"10.1016\/j.det.2019.05.005_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1590\/abd1806-4841.20153492","article-title":"Pityriasis lichenoides et varioliformis acuta after influenza vaccine","volume":"90","author":"de Castro","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.det.2019.05.005_bib17","first-page":"737428","article-title":"Pityriasis lichenoides chronica associated with herpes simplex virus type 2","volume":"2012","author":"Gonz\u00e1lez Rodr\u00edguez","year":"2012","journal-title":"Case Rep Dermatol Med"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jdcr.2016.06.012","article-title":"Pityriasis lichenoides chronica-like drug eruption developing during pembrolizumab treatment for metastatic melanoma","volume":"2","author":"Mutgi","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0560.1994.tb00250.x","article-title":"Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype","volume":"21","author":"Wood","year":"1994","journal-title":"J\u00a0Cutan Pathol"},{"issue":"3 Pt 1","key":"10.1016\/j.det.2019.05.005_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0190-9622(87)70074-7","article-title":"Immunohistology of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. Evidence for their interrelationship with lymphomatoid papulosis","volume":"16","author":"Wood","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2019.05.005_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/hupa.2002.125381","article-title":"Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder","volume":"33","author":"Magro","year":"2002","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.humpath.2006.09.013","article-title":"Pityriasis lichenoides chronica: stratification by molecular and phenotypic profile","volume":"38","author":"Magro","year":"2007","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000063906","article-title":"Cytotoxic mycosis fungoides evolving from pityriasis lichenoides chronica in a seventeen-year-old girl. Report of a case","volume":"205","author":"Tomasini","year":"2002","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pbc.23260","article-title":"Mycosis fungoides following pityriasis lichenoides: an exceptional event or a potential evolution","volume":"58","author":"Pileri","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2133.1978.tb02015.x","article-title":"An immunofluorescence study of pityriasis lichenoides","volume":"99","author":"Clayton","year":"1978","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ced.13351","article-title":"Possible role of plasmacytoid dendritic cells in pityriasis lichenoides","volume":"43","author":"Karouni","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib27","first-page":"27","article-title":"Pityriasis lichenoides et varioliformis acuta in skin of color: new observations by dermoscopy","volume":"7","author":"Ankad","year":"2017","journal-title":"Dermatol Pract Concept"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-4632.2008.03915.x","article-title":"Pityriasis lichenoides et varioliformis acuta: a disease spectrum","volume":"49","author":"Fernandes","year":"2010","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2019.05.005_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s13312-012-0212-4","article-title":"Pityriasis lichenoides","volume":"49","author":"Someshwar","year":"2012","journal-title":"Indian Pediatr"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000337745","article-title":"Pityriasis lichenoides et varioliformis acuta: case report and review of the literature","volume":"4","author":"Pereira","year":"2012","journal-title":"Case Rep Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1365-2133.2004.05920.x","article-title":"Successful treatment of pityriasis lichenoides with topical tacrolimus","volume":"150","author":"Simon","year":"2004","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ced.13035","article-title":"Treatment of adult diffuse pityriasis lichenoides chronica with narrowband ultraviolet B: experience and literature review","volume":"42","author":"Fern\u00e1ndez-Guarino","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib33","first-page":"198","article-title":"Pityriasis lichenoides chronica: good response to photodynamic therapy","volume":"158","author":"Fern\u00e1ndez-Guarino","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma","volume":"12","author":"Wilson","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","article-title":"Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients","volume":"74","author":"Wieser","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2019.05.005_bib37","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hoc.2016.11.006","article-title":"CD30+ lymphoproliferative disorders of the skin","volume":"31","author":"Sauder","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1016\/j.det.2019.05.005_bib39","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1240::AID-CNCR19>3.0.CO;2-X","article-title":"Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis","volume":"86","author":"Wang","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1634\/theoncologist.2015-0242","article-title":"Frequency and risk factors for associated lymphomas in patients with lymphomatoid papulosis","volume":"21","author":"Cordel","year":"2016","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.det.2019.05.005_bib41","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V94.9.3077","article-title":"CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: a clue to the pathophysiology of clinical regression","volume":"94","author":"Mori","year":"1999","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.det.2019.05.005_bib42","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.12788\/j.sder.2018.001","article-title":"Cutaneous CD30-positive T-cell lymphoproliferative disorders\u2014 clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Kempf","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"20","key":"10.1016\/j.det.2019.05.005_bib44","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archderm.140.4.441","article-title":"Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C","volume":"140","author":"El Shabrawi-Caelen","year":"2004","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.det.2019.05.005_bib47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.det.2019.05.005_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A\u00a0new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib49","first-page":"390","article-title":"Lymphomatoid papulosis - making sense of the alphabet soup: a proposal to simplify terminology","volume":"15","author":"Kempf","year":"2017","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: A study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semdp.2009.09.001","article-title":"Cutaneous CD30 lymphoproliferative disorders and similar conditions: a clinical and pathologic prospective on a complex issue","volume":"26","author":"Guitart","year":"2009","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib52","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood-2001-12-0199","article-title":"Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin","volume":"100","author":"Steinhoff","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.0022-202X.2004.22304.x","article-title":"The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative)","volume":"122","author":"Gellrich","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2019.05.005_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ced.13256","article-title":"First-line treatment in lymphomatoid papulosis: a retrospective multicentre study","volume":"43","author":"Fern\u00e1ndez-de-Misa","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2019.05.005_bib55","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaad.2015.03.001","article-title":"The efficacy of methotrexate for lymphomatoid papulosis","volume":"72","author":"Newland","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.05.005_bib56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0190-9622(96)90442-9","article-title":"Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders","volume":"34","author":"Vonderheid","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib57","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.13920","article-title":"Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group","volume":"173","author":"Bruijn","year":"2015","journal-title":"Br J Dermatol"},{"issue":"19","key":"10.1016\/j.det.2019.05.005_bib58","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1158\/1078-0432.CCR-09-0162","article-title":"A\u00a0phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders","volume":"15","author":"Duvic","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"10094","key":"10.1016\/j.det.2019.05.005_bib59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician\u2019s choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.det.2019.05.005_bib60","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30\u00a0+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.det.2019.05.005_bib61","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jamadermatol.2017.3593","article-title":"Brentuximab vedotin for patients with refractory lymphomatoid papulosis","volume":"153","author":"Lewis","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.005_bib62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.det.2015.05.013","article-title":"Practical management of CD30+ lymphoproliferative disorders","volume":"33","author":"Hughey","year":"2015","journal-title":"Dermatol Clin"},{"issue":"22","key":"10.1016\/j.det.2019.05.005_bib63","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.1826.1826","article-title":"First-in-human, multicenter phase I study of IPH4102, first-in-class humanized anti-KIR3DL2 monoclonal antibody, in relapsed\/refractory cutaneous T-cell lymphomas: preliminary safety, exploratory and clinical activity results","volume":"128","author":"Bagot","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.ijrobp.2007.08.077","article-title":"Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy","volume":"70","author":"Yu","year":"2008","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib65","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ijrobp.2016.03.023","article-title":"Radiation therapy for primary cutaneous anaplastic large cell lymphoma: an international lymphoma radiation oncology group multi-institutional experience","volume":"95","author":"Million","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.det.2019.05.005_bib66","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijrobp.2017.08.010","article-title":"Recommendations for the optimal radiation dose in patients with primary cutaneous anaplastic large cell lymphoma: a report of the Dutch cutaneous lymphoma group","volume":"99","author":"Melchers","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:44:38Z","timestamp":1760006678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863519300476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0733863519300476"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2019.05.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphomatoid Papulosis and Other Lymphoma-Like Diseases","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}